DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
endoxan is an investigational drug.
There have been 67 clinical trials for endoxan. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2004.
The most common disease conditions in clinical trials are Lymphoma, Leukemia, and Lymphoma, Non-Hodgkin. The leading clinical trial sponsors are National Cancer Institute (NCI), Sidney Kimmel Cancer Center at Thomas Jefferson University, and City of Hope Medical Center.
Recent Clinical Trials for endoxan
|A Study of a New Way to Treat Children With a Brain Tumor Called NGGCT||Children's Oncology Group||Phase 2|
|Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma||Lonza Walkersville, Inc.||Phase 1|
|Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma||Fred Hutchinson Cancer Research Center||Phase 1|